In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study

Kenneson, 2007, Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection, Rev Med Virol, 17, 253, 10.1002/rmv.535 Dollard, 2007, New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection, Rev Med Virol, 17, 355, 10.1002/rmv.544 Guerra, 2000, Prenatal diagnosis of symptomatic congenital cytomegalovirus infection, Am J Obstet Gynecol, 183, 476, 10.1067/mob.2000.106347 Benoist, 2008, The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus, BJOG, 115, 823, 10.1111/j.1471-0528.2008.01714.x Simonazzi, 2010, Fetal cerebral periventricular halo at midgestation: an ultrasound finding suggestive of fetal cytomegalovirus infection, Am J Obstet Gynecol, 202, 599.e1, 10.1016/j.ajog.2009.12.021 Fabbri, 2011, Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood, BJOG, 118, 448, 10.1111/j.1471-0528.2010.02822.x Feldman, 2011, Pregestational, periconceptional, and gestational primary maternal cytomegalovirus infection: prenatal diagnosis in 508 pregnancies, Am J Obstet Gynecol, 205, 342.e1, 10.1016/j.ajog.2011.05.030 Hughes, 2016, Society for Maternal-Fetal Medicine (SMFM) consult no. 39: diagnosis and antenatal management of congenital cytomegalovirus (CMV) infection, Am J Obstet Gynecol, 214, B5, 10.1016/j.ajog.2016.02.042 Benoist, 2008, Cytomegalovirus-related fetal brain lesions: comparison between targeted ultrasound examination and magnetic resonance imaging, Ultrasound Obstet Gynecol, 32, 900, 10.1002/uog.6129 Jacquemard, 2007, Maternal administration of valacyclovir in symptomatic intrauterine cytomegalovirus infection, BJOG, 114, 1113, 10.1111/j.1471-0528.2007.01308.x Griffiths, 2012, Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunization, Lancet Infect Dis, 12, 790, 10.1016/S1473-3099(12)70197-4 Nigro, 2005, Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection, N Engl J Med, 353, 1350, 10.1056/NEJMoa043337 Revello, 2014, A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus, N Engl J Med, 370, 1316, 10.1056/NEJMoa1310214 Kimberlin, 2015, Valganciclovir for symptomatic congenital cytomegalovirus disease, N Engl J Med, 372, 933, 10.1056/NEJMoa1404599 Tyms, 1981, The in vitro activity of acyclovir and related compounds against cytomegalovirus infections, J Antimicrob Chemother, 8, 65, 10.1093/jac/8.1.65 Lowance, 1999, Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group, N Engl J Med, 340, 1462, 10.1056/NEJM199905133401903 Stone, 2004, Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984-1999, Birth Defects Res A Clin Mol Teratol, 70, 201, 10.1002/bdra.20013 Pasternak, 2010, Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects, JAMA, 304, 859, 10.1001/jama.2010.1206 Duff, 2007, A thoughtful algorithm for the accurate diagnosis of primary CMV infection in pregnancy, Am J Obstet Gynecol, 196, 196, 10.1016/j.ajog.2006.09.020 Cahill, 2009, Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis, Am J Obstet Gynecol, 201, 466.e1, 10.1016/j.ajog.2009.07.056 Guerra, 2007, Impact of diagnostic and confirmatory tests and prenatal counseling on the rate of pregnancy termination among women with positive cytomegalovirus immunoglobulin M antibody titers, Am J Obstet Gynecol, 196, 221.e1, 10.1016/j.ajog.2006.08.039 Leruez-Ville, 2013, Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: a retrospective cohort, Clin Infect Dis, 56, 1428, 10.1093/cid/cit059 Simon, 1989, Optimal two-stage designs for phase II clinical trials, Control Clin Trials, 10, 1, 10.1016/0197-2456(89)90015-9 Picone, 2008, Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection, Prenat Diagn, 28, 753, 10.1002/pd.2037 Guerra, 2008, Ultrasound prediction of symptomatic congenital cytomegalovirus infection, Am J Obstet Gynecol, 198, 380.e1, 10.1016/j.ajog.2007.09.052 Jung, 2004, On the estimation of the binomial probability in multistage clinical trials, Stat Med, 23, 881, 10.1002/sim.1653 Meher-Homji, 1994, Platelet size and glycoprotein Ib and IIIa expression in normal fetal and maternal blood, Am J Obstet Gynecol, 171, 791, 10.1016/0002-9378(94)90099-X Gaytant, 2002, Congenital cytomegalovirus infection: review of the epidemiology and outcome, Obstet Gynecol Surv, 57, 245, 10.1097/00006254-200204000-00024 Picone, 2013, A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome, Prenat Diagn, 33, 751, 10.1002/pd.4118 Farkas, 2011, Does normal fetal brain ultrasound predict normal neurodevelopmental outcome in congenital cytomegalovirus infection?, Prenat Diagn, 31, 360, 10.1002/pd.2694 Boppana, 2005, Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss, J Pediatr, 146, 817, 10.1016/j.jpeds.2005.01.059 Liesnard, 2000, Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk, Obstet Gynecol, 95, 881 Lipitz, 2010, Value of prenatal ultrasound and magnetic resonance imaging in assessment of congenital primary cytomegalovirus infection, Ultrasound Obstet Gynecol, 36, 709, 10.1002/uog.7657 Griffiths, 1998, J Infect Dis, 177, 57, 10.1086/513806 Emery, 1999, J Infect Dis, 180, 695, 10.1086/314936 Zavattoni, 2014, Maternal, fetal, and neonatal parameters for prognosis and counseling of HCMV congenital infection, J Med Virol, 86, 2163, 10.1002/jmv.23954 Forner, 2015, High cytomegalovirus (CMV) DNAemia predicts CMV sequelae in asymptomatic congenitally infected newborns born to women with primary infection during pregnancy, J Infect Dis, 212, 67, 10.1093/infdis/jiu627 Vauloup-Fellous, 2007, Evaluation of cytomegalovirus (CMV) DNA quantification in dried blood spots: retrospective study of CMV congenital infection, J Clin Microbiol, 45, 3804, 10.1128/JCM.01654-07 Walter, 2008, Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss, Arch Dis Child Fetal Neonatal Ed, 93, F280, 10.1136/adc.2007.119230 Morris, 2013, Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomized trial, Lancet, 382, 1496, 10.1016/S0140-6736(13)60992-7 Relton, 2010, Rethinking pragmatic randomized controlled trials: introducing the “cohort multiple randomized controlled trial” design, BMJ, 340, c1066, 10.1136/bmj.c1066 Hadlock, 1985, Estimation of fetal weight with the use of head, body, and femur measurements–a prospective study, Am J Obstet Gynecol, 151, 333, 10.1016/0002-9378(85)90298-4 Grannum, 1983, Ultrasound examination of the placenta, Clin Obstet Gynaecol, 10, 459, 10.1016/S0306-3356(21)00585-9 Vintzileos, 1985, Fetal liver ultrasound measurements during normal pregnancy, Obstet Gynecol, 66, 477 Hata, 1992, A review of fetal organ measurements obtained with ultrasound: normal growth, J Clin Ultrasound, 20, 155, 10.1002/jcu.1870200302 Slotnick, 1996, Prognostic implications of fetal echogenic bowel, Lancet, 347, 85, 10.1016/S0140-6736(96)90210-X